Compare ELMD & SAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELMD | SAR |
|---|---|---|
| Founded | 1992 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 226.4M | 233.9M |
| IPO Year | 2010 | 2006 |
| Metric | ELMD | SAR |
|---|---|---|
| Price | $26.74 | $13.82 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 7 |
| Target Price | ★ $48.50 | $20.00 |
| AVG Volume (30 Days) | 61.1K | ★ 163.5K |
| Earning Date | 11-11-2026 | 10-06-2026 |
| Dividend Yield | N/A | ★ 21.64% |
| EPS Growth | ★ 52.94 | 14.36 |
| EPS | ★ 1.30 | N/A |
| Revenue | ★ $54,716,000.00 | N/A |
| Revenue This Year | $12.71 | $0.78 |
| Revenue Next Year | $10.70 | $6.28 |
| P/E Ratio | $20.65 | ★ N/A |
| Revenue Growth | ★ 13.83 | N/A |
| 52 Week Low | $23.01 | $13.52 |
| 52 Week High | $47.40 | $24.07 |
| Indicator | ELMD | SAR |
|---|---|---|
| Relative Strength Index (RSI) | 34.72 | 23.99 |
| Support Level | $23.06 | $13.78 |
| Resistance Level | $28.65 | $15.48 |
| Average True Range (ATR) | 0.72 | 0.59 |
| MACD | 0.13 | -0.10 |
| Stochastic Oscillator | 14.55 | 11.07 |
Electromed Inc is a United States-based company that develops, manufactures and markets airway clearance products that apply High Frequency Chest Wall Oscillation (HFCWO) therapy in pulmonary care for patients of all ages. The company markets its products in the U.S. to the homecare and hospital markets. Its product includes the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The company operates in a single segment: developing, manufacturing, and marketing medical equipment. The company generates revenue from Homecare, Hospital, Homecare Distributor, and Other.
Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The company invests in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.